Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Coaching lowers blood pressure in kidney patients

NCT ID NCT04087798

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an educational worksheet plus health coaching could help people with chronic kidney disease improve their blood pressure. 320 adults with moderate to severe kidney disease and uncontrolled high blood pressure took part. The goal was to see if the coaching group had better blood pressure control after 12 months compared to those who did not receive coaching.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

320 people

The number who actually took part.

Started

Feb 2020

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of CKD stage 3, 4, or 5 documented in medical record * Aware of CKD diagnosis * Has diagnosis of hypertension documented in medical record and most recent Blood Pressure (BP) within the last year meets criteria of uncontrolled hypertension (≥140 mmHg, and/or a diastolic blood pressure ≥90 mmHg noted in an ambulatory care setting within the past one year) * Estimated glomerular filtration rate (eGFR) of \<60 within the last 18 months documented in the medical record Exclusion Criteria: * Currently on dialysis permanently (i.e. are considered "end-stage renal disease" and receiving dialysis) * Previous kidney transplant * Pregnant (indicated by medical record or if patient self-identifies as pregnant) * Has cognitive, language, or vision impairment(s) that would prohibit participating in education, taking surveys, or participating in coaching activities * Has terminal illness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Health Center - GMAP/Gen Med

    Detroit, Michigan, 48201, United States

  • University Health Center - Med Peds

    Detroit, Michigan, 48201, United States

  • University of Michigan / Briarwood Family Medicine

    Ann Arbor, Michigan, 48108, United States

  • University of Michigan / Brighton Health Center

    Brighton, Michigan, 48116, United States

  • University of Michigan / Canton Health Center

    Canton, Michigan, 48187, United States

  • University of Michigan / Chelsea Health Center

    Chelsea, Michigan, 48118, United States

  • University of Michigan / Dexter Health Center

    Dexter, Michigan, 48130, United States

  • University of Michigan / Domino's Farms

    Ann Arbor, Michigan, 48105, United States

  • University of Michigan / Livonia Health Center

    Livonia, Michigan, 48152, United States

  • University of Michigan / Northville Health Center

    Northville, Michigan, 48168, United States

  • University of Michigan / Ypsilanti Health Center

    Ypsilanti, Michigan, 48198, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.